Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)
PHASE2
The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)
PHASE3
This study will evaluate the efficacy and safety of a FDC of imipenem/cilas...
Status
Completed
Location
Santa Casa de Misericordia de Belo Horizonte ( Site 0300)
Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
PHASE3
The study will evaluate the efficacy and safety of imipenem+cilastatin/rele...
Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)
PHASE3
The study will evaluate the efficacy and safety of imipenem+cilastatin/rele...
Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)
PHASE2
The primary purpose of this study is to evaluate the safety and tolerabilit...
Safety, Tolerability, and Efficacy of MK-7655 (Relebactam) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for Treating Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
PHASE2
The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver Transplantation
PHASE3
This is a multicenter stepped-wedge cluster randomized trial, conducted ove...
Status
Not Yet Recruiting
Location
Irccs Azienda Ospedaliero-Universitaria Di Bologna